Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes

被引：0
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, 1 1 5 Sendagi Bunkyo Ku, Tokyo 1138602, Japan
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2023年 / 37卷 / 04期
关键词：
OUTCOMES;
D O I：
10.1007/s10557-022-07374-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 620
页数：2
相关论文
共 50 条
  • [11] Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes: a magic potion to reduce heart failure?
    Pafili, K.
    Papanas, N.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 693 - 695
  • [12] The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure, Regardless of Diabetes Status: Focus on Cardiovascular Disease
    Ferrari, Filipe
    Martins, Vitor M.
    Scheffel, Rafael S.
    da Silveira, Anderson D.
    Motta, Marcelo Trotte
    Moriguchi, Emilio H.
    Santos, Raul D.
    Stein, Ricardo
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (10) : 1267 - 1275
  • [13] Pathophysiological explanation of cardiovascular benefits of sodium-glucose cotransporter-2 inhibitors by neurotrophic theory
    Hristova, Mariyana
    MEDICAL HYPOTHESES, 2017, 102 : 61 - 64
  • [14] Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus
    Kambara, Takahiro
    Shibata, Rei
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    Murohara, Toyoaki
    Ajioka, Masayoshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (01) : 108 - 114
  • [15] Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease
    Lee, Sook Jung
    Lee, Kook Hyung
    Oh, Hyun Geong
    Seo, Hye Ji
    Jeong, Soo Jin
    Kim, Chong Hwa
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2019, 28 (04) : 254 - 261
  • [16] Diving into the unknown: sodium-glucose cotransporter-2 inhibitors in heart failure without diabetes
    Seferovic, Petar M.
    Seferovic, Jelena P.
    Polovina, Marija M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (07) : 874 - 876
  • [17] Sodium-glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?
    Snaith, Jennifer R.
    Greenfield, Jerry R.
    MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (03) : 126 - 128
  • [18] Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study
    Fu, Edouard L. L.
    D'Andrea, Elvira
    Wexler, Deborah J.
    Patorno, Elisabetta
    Paik, Julie M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (05): : 592 - 601
  • [19] Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review
    Dubrofsky, Lisa
    Srivastava, Anand
    Cherney, David Z.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2020, 7
  • [20] Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review
    Sarker, Aditi
    Ramesh, Adarsh Srinivas
    Munoz, Carlos
    Jamil, Dawood
    Tran, Hadrian Hoang-Vu
    Mansoor, Mafaz
    Butt, Samia Rauf
    Satnarine, Travis
    Ratna, Pranuthi
    Hamid, Pousette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
12345